Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q3 2022
Institutional positions in Cidara Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −4 vs. Q2 2022
- Shares held
- 27.1M
- −142.6K (−0.5%) vs. Q2 2022
- Total value
- $17.1M
- +$3.77M (+28.3%) vs. Q2 2022
- New holders
- 5
- 11 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 6,861,127 | $4.31M | 0.18% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 4,559,201 | $2.92M | 0.29% | −259,889−5.4% | Reduced |
| Point72 Asset Management, L.P. | 3,868,006 | $2.43M | 0.01% | −331,994−7.9% | Reduced |
| Vanguard Group Inc | 2,467,933 | $1.55M | 0.00% | +6,300+0.3% | Added |
| Alethea Capital Management, LLC | 1,677,194 | $1.05M | 1.33% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,293,273 | $812.0K | 0.00% | +137,016+11.8% | Added |
| Acadian Asset Management LLC | 1,213,531 | $760.0K | 0.00% | +98,694+8.9% | Added |
| 5AM Venture Management, LLC | 1,134,511 | $712.0K | 0.14% | 00.0% | Unchanged |
| Knott David M Jr | 686,027 | $431.0K | 0.20% | +50,773+8.0% | Added |
| Geode Capital Management, LLC | 584,981 | $367.0K | 0.00% | +82,932+16.5% | Added |
| West Family Investments, Inc. | 368,910 | $232.0K | 0.10% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 369,099 | $232.0K | 0.09% | +369,099 | New |
| US Bancorp | 262,072 | $165.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 230,937 | $145.0K | 0.00% | +54,700+31.0% | Added |
| Artal Group S.A. | 224,675 | $141.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 196,609 | $124.0K | 0.00% | −36,579−15.7% | Reduced |
| Jeppson Wealth Management, LLC | 174,175 | $109.0K | 0.05% | −6,900−3.8% | Reduced |
| Bridgeway Capital Management, LLC | 140,000 | $88.0K | 0.00% | −100,000−41.7% | Reduced |
| Northern Trust Corp | 105,490 | $66.0K | 0.00% | +7,097+7.2% | Added |
| Tocqueville Asset Management L.P. | 104,000 | $65.0K | 0.00% | +104,000 | New |
| Raymond James Financial Services Advisors, Inc. | 88,686 | $56.0K | 0.00% | +1,947+2.2% | Added |
| Millennium Management LLC | 83,716 | $53.0K | 0.00% | +32,062+62.1% | Added |
| Goldman Sachs Group Inc | 72,391 | $45.0K | 0.00% | −6,171−7.9% | Reduced |
| Prudential Financial Inc | 54,000 | $34.0K | 0.00% | +54,000 | New |
| Aveo Capital Partners, LLC | 42,502 | $27.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 41,819 | $26.0K | 0.00% | +41,819 | New |
| Two Sigma Advisers, LP | 28,200 | $18.0K | 0.00% | −10,494−27.1% | Reduced |
| Advisor Group Holdings, Inc. | 22,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 20,889 | $13.0K | 0.00% | −4,997−19.3% | Reduced |
| HSBC Holdings PLC | 17,001 | $11.0K | 0.00% | −18,258−51.8% | Reduced |
| Fisher Asset Management, LLC | 16,500 | $10.0K | 0.00% | −2,300−12.2% | Reduced |
| Russell Investments Group, Ltd. | 17,100 | $10.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 12,823 | $8.00K | 0.00% | −9,404−42.3% | Reduced |
| Stratos Wealth Partners, LTD. | 10,489 | $7.00K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 11,672 | $7.00K | 0.00% | +11,672 | New |
| Pacifica Partners Inc. | 8,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 800 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 353 | $222 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 243 | $0 | 0.00% | +33+15.7% | Added |
| Wells Fargo & Company | 409 | $0 | 0.00% | +12+3.0% | Added |
| Group One Trading, L.P. | 405 | $0 | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −208,443−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −57,350−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −44,185−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,625−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −25,157−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −11,397−100.0% | Sold out |
| Shufro Rose & Co LLC | 0 | $0 | 0.00% | −10,413−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,208−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −11−100.0% | Sold out |